Strategic Market Access Ensures the Right Treatments at the Right Time

Successfully navigating market access and reimbursement ensures pharmaceutical products remain affordable and attainable for payers and patients. A robust market access strategy ensures these products, including those with limited distribution, reach patients and are covered by a diverse healthcare system. This process forms the foundation for achieving sustainability for the healthcare payer and pharmaceutical manufacturer, ultimately improving accessibility and enhancing the patient care experience. Craig Caceci, Executive Vice President and Managing Director, EU/UK of AscellaHealth, explores this topic in Pharmaceutical Executive.

To read more, click here